0.524
1.22%
0.0063
Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
44.34%
0.00121
|
0.00217 | 0.0159 | 0.00611 | 0.1283 |
Cost Of Revenue |
99.80%
0.000277
|
0.1392 | 0.0296 | 0.073 | 0.0602 |
Gross Profit |
100.68%
0.000928
|
-0.137 | -0.0137 | -0.0669 | 0.068 |
Operating Expenses
|
88.83%
3.4453
|
1.8246 | 2.1411 | 2.127 | 1.9742 |
Interest Income/Expense |
37.94%
0.6847
|
1.1033 | 1.2186 | 0.1148 | 0.0567 |
Benefits Costs and Expenses |
26.16%
3.9822
|
3.1566 | 3.385 | 2.2396 | 2.0255 |
Costs And Expenses |
26.16%
3.9822
|
3.1566 | 3.385 | 2.2396 | 2.0255 |
Operating Income/Loss |
75.59%
-3.4444
|
-1.9616 | -2.1549 | -2.1938 | -1.9062 |
Nonoperating Income/Loss |
-0.5366
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
26.20%
-3.981
|
-3.1544 | -3.3691 | -2.2335 | -1.8972 |
Income/Loss From Continuing Operations After Tax |
19.56%
-3.981
|
-3.3298 | -3.3681 | -2.3152 | -1.8972 |
Net Income/Loss
|
19.56%
-3.981
|
-3.3298 | -3.3681 | -2.3152 | -1.8972 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
78.04%
-0.048
|
-0.2188 | -0.0506 | -0.0517 | -0.0735 |
Basic Average Shares |
1,148%
9.7362
|
0.7802 | 4.0553 | 3.3087 | 33.08 |
Diluted Average Shares |
1,148%
9.7362
|
0.7802 | 4.0553 | 3.3087 | 33.08 |
Basic Earnings Per Share |
14.29%
-0.40
|
-0.35 | -0.82 | -0.68 | -0.06 |
Diluted Earnings Per Share |
14.29%
-0.40
|
-0.35 | -0.82 | -0.68 | -0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):